Fintech PR

CIIE leads global development to new, bright prospects

Published

6 months ago

November 5, 2023

BEIJING, Nov. 5, 2023 /PRNewswire/ — A report from People’s Daily: The sixth China International Import Expo (CIIE) will be held at the National Exhibition and Convention Center (Shanghai) from Nov. 5 to 10.

The CIIE, a pioneering event in the history of international trade development, has become a showcase of China’s new development pattern, a platform for high-level opening-up, and a public good shared by the whole world.

This year’s CIIE fully resumes offline activities, and is expected to welcome guests from 154 countries, regions, and international organizations. So far, 69 countries and three international organizations have confirmed their participation in the Country Exhibition. Over 3,400 exhibitors and nearly 410,000 professional visitors have registered for the event, with a record number of Global Fortune 500 companies and industry leaders in attendance.

Since the first CIIE, many participating companies have expressed similar sentiments, speaking of the tremendous appeal of the event. Some said they would bring their best and latest products to the event, and some promised to introduce their countries’ specialties. For them, the CIIE brings not just orders, but also the future and hopes.

The achievements of the past five editions of the CIIE have been remarkable: 131 countries and international organizations participated in the Country Exhibition; over 15,000 exhibitors joined the Business Exhibition; the cumulative number of registered visitors exceeded 2 million; the cumulative intended turnover amounted to $350 billion.

The CIIE not only attracts multinational companies, but also gathers upstream and downstream enterprises, providing opportunities for cooperation for various industries to reorganize and optimize themselves on a global scale. Many exhibitors said that at the CIIE, they can deepen exchanges with companies and partners in the same industry or even across industries, and discuss cooperation prospects together.

The previous five sessions of the CIIE have seen debuts of around 2,000 new and innovative products, technologies and services, including intelligent mobile hospitals, hydrogen-fueled concept cars, direct-injection digital printers, and vertical farms. It has become an incubator for technological innovation with global impact.

The CIIE also provides free standard booths and fee reduction measures for the least developed countries. It has been joined by enterprises from 43 least developed countries in the previous five sessions.

With the help of the CIIE, products such as coffee from Timor-Leste, pine nuts from Afghanistan, and cashews from Cambodia have achieved unprecedented sales in the Chinese market.

The “CIIE effect” continues to amplify. The Hongqiao Import Commodity Exhibition and Trading Center provides a permanent exhibition and sales platform for small and medium-sized enterprises participating in the CIIE. Since the first CIIE, Shanghai has recognized a total of 60 “6+365” trading platforms and introduced nearly 270,000 types of exhibits, with a cumulative import value of over 323 billion yuan ($44.22 billion).

German multinational glass company Schott AG said the CIIE presents a vivid and lively representation of the entire Chinese market. The company participated in the first CIIE with a “give it a try” attitude. From then on, it attended the expo every year, increased its investment and even established new factories in China.

The head of Schott China stated that with the expo, the company has achieved unparalleled growth, and continuing to invest in the Chinese market is a strategic choice for the future.

Thanks to the CIIE, exhibits have turned into commodities and exhibitors have become investors. An increasing number of multinational corporations are deeply integrated into China’s industrial and innovation networks.

Since the beginning of this year, multinational companies have continued to increase investment and expand production in China, with projects progressing at a faster pace. Global refrigeration industry giant Danfoss has put into operation a global refrigeration R&D testing center, German chemical giant BASF’s integrated base has started construction on its syngas facility in Zhanjiang, south China’s Guangdong province, and Airbus has begun construction on its second final assembly line for the A320 series aircraft in Tianjin.

In the first nine months of this year, China has established 37,814 new foreign-invested enterprises, with a year-on-year increase of 32.4 percent.

The CIIE mirrors the resilience and vitality of the Chinese economy, to deepen reform and pursue high-quality development through greater openness.

For some time now, the global economic recovery has faced headwinds, but China has withstood the pressures and continued its rebound, with its economic growth among the highest in major economies worldwide.

China is steadfastly pushing for higher-level opening up, and actively expanding imports. It has remained the world’s second-largest import market for 14 consecutive years. With a population of over 1.4 billion and a middle-income group of over 400 million people, China constitutes the world’s second-largest consumer market and the largest online retail market.

Kenneth Jarrett, president of the American Chamber of Commerce in Shanghai, noted that many companies with global markets need to achieve economies of scale, and if they don’t come to China, they won’t be able to reach the economic scale needed to maintain global competitiveness.

Chinese President Xi Jinping said that opening up is the hallmark of contemporary China. In his keynote speeches and addresses delivered at the previous five sessions of the CIIE, the word “openness” was mentioned over 100 times. The measures he announced at the CIIE to expand opening up have been gradually implemented, effectively promoting new progress in high-level opening-up.

China has established the Lingang new area of the China (Shanghai) Pilot Free Trade Zone, implemented an integrated development strategy in the Yangtze River Delta region, released an overall plan for the construction of the Hainan Free Trade Port, further expanded reform and opening up in Shenzhen, continuously improved business environment, and strengthened intellectual property protection.

China has deepened reform by opening up, and conversely, pursued deeper reforms to enable greater openness. This benefits not only China’s own development but also the world.

The CIIE belongs not just to China, but to the world. Looking ahead, China is willing to work together with all countries to practice true multilateralism, build a greater consensus of openness, jointly overcome the difficulties and challenges facing global economic development, and usher in a brighter future for development worldwide through opening up.

View original content:https://www.prnewswire.co.uk/news-releases/ciie-leads-global-development-to-new-bright-prospects-301977891.html

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

4 weeks ago

April 5, 2024

CISION (PR Newswire)

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf	Invitation to presentation of EQT AB’s Q1 Announcement 2024
https://news.cision.com/eqt/i/eqt-ab-group,c3285895	EQT AB Group

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

4 weeks ago

April 5, 2024

CISION (PR Newswire)

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs

Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

4 weeks ago

April 5, 2024

CISION (PR Newswire)

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html